Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared a post on LinkedIn:
“Destiny Breast 06 trial is making news again after the FDA approval. These were my thoughts about that trial immediately after it was presented at ESMO24. Check it out. Starts at 5:54.”